 STAMFORD, Conn., May 03, 2022 GLOBE NEWSWIRE -- Cara Therapeutics, Inc. Nasdaq: CARA, an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the following investor conferences in May: 